Soleno Therapeutics Faces Securities Fraud Lawsuit Over DCCR Safety Claims
Class action lawsuit filed against $SLNO over alleged securities fraud tied to DCCR drug safety concerns, patient death, and disappointing Q3 results.
SLNOsecurities fraudclass action lawsuit